COVID-19 S. Korea set to resume AstraZeneca jabs amid lingering safety woes
페이지 정보
본문
S. Korea set to resume AstraZeneca jabs amid lingering safety woes (koreaherald.com) Apr 8,2021
#Vaccine
#AstraZeneca
#Advantages and risks
#1,075,574 people, 2.06% of total population was inoculated
관련링크
- Prev(2nd LD) AstraZeneca vaccine rollout resumed, those under 30 excluded 21.04.12
- NextS. Korea to extend current social distancing measures for 2 weeks 21.04.02
댓글목록
There are no registered comments.